Tag Archives: Center for Diagnostic Imaging

The Center for Diagnostic Imaging is the premier diagnostic facility in North Miami Beach, committed to providing the best in digital imaging and patient care.

CDI Miami | Wednesday January 20, 2016

Stereotactic Breast Biopsy

Stereotactic breast biopsy uses mammography – a specific kind of low-dose breast imaging that helps locate a breast lump or abnormality and remove tissue sample for examination under a microscope. It’s less invasive than surgical biopsy, leaves little to no scarring and can be an excellent way to evaluate calcium deposits or tiny masses that are not visible on ultrasound.

What is Mammographically Guided Breast Biopsy?

A breast biopsy is performed to remove suspicious area in the breast and examine them under a microscope. Suspicious areas may include:

    • An unidentified mass
    • Microcalcifications, a tiny cluster of small calcium deposits
    • A distortion in the structure of the breast tissue
    • An area of abnormal tissue change
    • A new mass or area of calcium deposits is present at a previous surgery site

 

 

How should I prepare?

Before the exam, you may be asked to remove some or all of your clothes and to wear a gown during the exam. You will have to remove jewelry, dental appliances, eye glasses and any metal objects or clothing that might interfere with the x-ray images.
You should also report all medications that you are taking – including herbal supplements.

How is the procedure performed?

– Breast biopsies are usually done on an outpatient basis.

– In most cases, you will lie face down on a moveable exam table and the affected breast will be positioned into an opening in the table.

– The table is raised and the procedure is then performed beneath it. If the machine is an upright system, you may be seated in front of the stereotactic mammography unit.

– The breast is compressed and held in position throughout the procedure.

– Preliminary stereotactic mammogram images are taken.

– A local anesthetic will be injected into the breast to numb it.

– A very small nick is made in the skin at the site where the biopsy needle is to be inserted.

 

RadiologyInfo explains the pros and cons of this procedure:

 

Benefits:

– The procedure is less invasive than surgical biopsy, leaves little or no scarring and can be performed in less than an hour.

– Stereotactic breast biopsy is an excellent way to evaluate calcium deposits or masses that are not visible on ultrasound.

– Stereotactic core needle biopsy is a simple procedure that may be performed in an outpatient imaging center.

– Compared with open surgical biopsy, the procedure is about one-third the cost.

– Very little recovery time is required.

– Generally, the procedure is not painful.

– No breast defect remains and, unlike surgery, stereotactic needle biopsy does not distort the breast tissue and make it difficult to read future mammograms.

– Recovery time is brief and patients can soon resume their usual activities.

– No radiation remains in a patient’s body after an x-ray examination.

– X-rays usually have no side effects in the typical diagnostic range for this exam.

 

Risks:

 

– There is a risk of bleeding and forming a hematoma, or a collection of blood at the biopsy site. The risk, however, appears to be less than one percent of patients.

– An occasional patient has significant discomfort, which can be readily controlled by non-prescription pain medication.

– Any procedure where the skin is penetrated carries a risk of infection. The chance of infection requiring antibiotic treatment appears to be less than one in 1,000.

– Depending on the type of biopsy being performed or the design of the biopsy machine, a biopsy of tissue located deep within the breast carries a slight risk that the needle will pass through the chest wall, allowing air around the lung that could cause the lung to collapse. This is an extremely rare occurrence.

– There is always a slight chance of cancer from excessive exposure to radiation. However, the benefit of an accurate diagnosis far outweighs the risk.

– Women should always inform their physician or x-ray technologist if there is any possibility that they are pregnant. See the Safety page for more information about pregnancy and x-rays.

 

As medical imaging technology continues to advance, it is important to stay informed of the latest treatments so that your healthcare can become simpler and easier. Schedule your exam today and benefit!

CDI Miami | Tuesday December 8, 2015

3D Mammography Aids in Early Cancer Detection

According to a new study, digital breast tomosynthesis, or 3D mammography, can improve the detection of breast cancer, according to a new study.

 

Continue reading

CDI Miami | Tuesday November 17, 2015

CDI’s Latest Technology to Help Maintain and Improve Health

The Center for Diagnostic Imaging of Miami, announces helping patients maintain their healthy lifestyles and improving chances of catching and treating severe illnesses and diseases, with their latest full body scanning technology.

The medical technology used to operate full body scans are noninvasive, painless and require low dosages of radiation.

Continue reading

CDI Miami | Thursday November 5, 2015

Optical Imaging Innovation Expected to Revolutionize Digital Imaging

Electrical engineers at the University of Wisconson-Madison have created the fastest, most responsive flexible silicon phototransistor ever made.

The phototransistor could improve the performance of myriad products – from digital cameras, night-vision goggles and surveillance systems to medical and digital imaging.

“Developed by UW-Madison collaborators Zhenqiang “Jack” Ma, professor of electrical and computer engineering, and research scientist Jung Hun Seo, the high-performance phototransistor far and away exceeds all previous flexible phototransistor parameters, including sensitivity and response time, according to the university.” – Security Sales

Similar to human eyes, phototransistors essentially sense and collect light, then convert that light into an electrical charge proportional to its intensity and wavelength. In the case of human eyes, the electrical impulses transmit the image to the brain.

“We actually can make the curve any shape we like to fit the optical system,” Ma says. “Currently, there’s no easy way to do that.”

One important aspect of the success of the new phototransistors is the researchers’ innovative “flip-transfer” fabrication method, in which their final step is to invert the finished phototransistor onto a plastic substrate. At that point, a reflective metal layer is on the bottom.

“In this structure – unlike other photodetectors – light absorption in an ultrathin silicon layer can be much more efficient because light is not blocked by any metal layers or other materials,” Ma says.

The researchers are patenting the technology through the Wisconsin Alumni Research Foundation.

Original article found here.

CDI Miami | Tuesday September 29, 2015

Chemotherapy May Not Be Needed for Early-Stage Breast Cancer

A recent study shows that early-stage tumors may respond to drug-therapy alone

Continue reading

CDI Miami | Friday September 18, 2015

Ultrasounds: Non-Nuclear, Preventive Care

It is well known that ultrasound technology is often used to monitor the growth of babies still in the womb; to determine due dates, prenatal health, and the sex of the child. However, ultrasound technology, which uses a transducer to transmit high-frequency sound waves into the body and translates them into images, can be also used to diagnose and prevent a wide range of conditions. Continue reading

CDI Miami | Tuesday July 21, 2015

MRIs and Peace – One Scan at a Time

At MIT, a collaboration is underway making the MRI scanner a new tool for resolving war and conflict. The goal of the lab is to use current knowledge of neuroscience to develop innovative, science-based conflict resolution strategies.

Continue reading

CDI Miami | Monday June 1, 2015

June is Alzheimer’s Awareness Month.

Current diagnosis of Alzheimer’s relies largely on documenting mental decline. Individuals who are diagnosed in this manner have already suffered severe brain damage. Neuroimaging is among the most promising areas of research focused on early detection. Today, a standard screening for Alzheimer’s includes structural imaging with magnetic resonance imaging (MRI) or computed tomography (CT). These tests are used to screen for diseases similar to Alzheimer’s that require different treatment methods. Structural imaging can reveal tumors, head trauma, or strokes.

Recently, the U.S. Food and Drug Administration approved the first molecular tracer for use of patients being evaluated for Alzheimer’s disease. This tracer is radioactive allowing it to be seen during a positron emission tomography (PET) brain scan, broadening the scope of treatment.

A task force of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association recently published criteria dictating when certain diagnostic imaging procedures for Alzheimer’s evaluation was appropriate.

Structural Imaging

Structural imaging studies have revealed that the brains of people with Alzheimer’s shrink significantly as the disease progresses. Research has increasingly determined that shrinkage of specific areas of the brain – such as the hippocampus, may be an early sign of Alzheimer’s. However, scientists have yet to agree on standardized values for brain volume that would establish the significance of a specific degree of shrinkage for anyone person.

Functional Imaging

Functional imaging research with positron emission tomography (PET) and other methods suggest that people with Alzheimer’s have less brain activity in certain areas. Alzheimer’s often parallels deficiencies of glucose in areas known for processing memory, learning and executive function. However promising these studies may be, research is still in its nascent stages and no conclusive patterns can be established for diagnostic information about individuals.

Molecular Imaging Technologies

Molecular imaging technologies are on the forefront of new approaches to diagnose Alzheimer’s in its earliest stages. Molecular diagnostics may be able to detect biological cues long before the disease causes permanent damage to the brain’s structure or function. Molecular imaging offers a new strategy for monitoring disease progression and assess next-generation disease treatments.

Fortunately, the strengths and weakness of available imaging technologies are complementary. This has led to multi-modal imaging studies in which several techniques are simultaneously or sequentially applied to the same subjects for the same period of time. The value of any imaging technology will be determined by its efficacy in finding and implementing therapies. The value is inclusive of contributions to diagnosis. Because imaging technology’s most effective use in the treatment of Alzheimer’s has been early-stage evaluation, there has been an interest in “prevention” studies. Research is being done to see whether therapies are having a disease-modifying effect that could potentially translate into a delay in clinical onset.


For more information on, or to set up an appointment with The Center for Diagnostic Imaging, call 1-800-371-0002.

CDI Miami | Thursday May 7, 2015

National Cancer Institute grants $2.88 Million for Research and Development of Breast CT Scanning

CT scan of large breast tumor

CT Scan of a large breast tumor.
Image Source: RadiologyInfo.org

The National Cancer Institute recently awarded John M. Boone, a UC Davis professor of radiology and medical physicist, with an award of $2.88 million to advance and study computed tomography (CT) as a detection technique for breast cancer.

 

Continue reading

CDI Miami | Friday March 6, 2015

Medicare Reforms are Endangering Outpatient Imaging Centers

meidcare cuts imaging reimbusement Since the Deficit Reduction Act of 2005, “Medicare has been dropping reimbursement for mostly the technical component and to a lesser extent the professional component of advanced imaging,” said David C. Levin, M.D., professor and chairman emeritus of the radiology department at Thomas Jefferson University Hospital, in an interview for the Radiological Society of North America. “As they drop reimbursements, we’re seeing private offices begin to close, so the work is shifting to hospitals.” Since being deployed in 2007, the Deficit Reduction Act has cut imaging reimbursement significantly, with the goal of $8 billion over 10 years. Continue reading